{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:28:31Z","timestamp":1792189711274,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jpainsymman.2024.02.008","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:44:09Z","timestamp":1707756249000},"page":"441-452.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6482-7874","authenticated-orcid":false,"given":"Natsuki","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-1184","authenticated-orcid":false,"given":"Naosuke","family":"Yokomichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuko","family":"Yabuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hisanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-1667","authenticated-orcid":false,"given":"Satoru","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0001","article-title":"Drug therapy for delirium in terminally ill adults","volume":"1","author":"Finucane","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0002","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.mcna.2020.01.006","article-title":"Delirium at the end of life","volume":"104","author":"Agar","year":"2020","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0003","doi-asserted-by":"crossref","first-page":"i3085","DOI":"10.1136\/bmj.i3085","article-title":"Delirium and agitation at the end of life","volume":"353","author":"Hosker","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0004","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.3390\/cancers13235893","article-title":"Delirium in palliative care","volume":"13","author":"Bramati","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0005","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.24215","article-title":"Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers","volume":"115","author":"Bruera","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/appi.psy.43.3.183","article-title":"The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouse\/caregivers, and their nurses","volume":"43","author":"Breitbart","year":"2002","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.psy.45.2.107","article-title":"Family-perceived distress from delirium-related symptoms of terminally ill cancer patients","volume":"45","author":"Morita","year":"2004","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0008","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/pon.5915","article-title":"Association between experiences of advanced cancer patients at the end of life and depression in their bereaved caregivers","volume":"31","author":"Hatano","year":"2022","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0009","article-title":"Palliative pharmacological sedation for terminally ill adults","volume":"1","author":"Beller","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0885-3924(94)90193-7","article-title":"The use of chlorpromazine for symptom control in dying cancer patients","volume":"9","author":"Mclver","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0011","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00520-008-0459-4","article-title":"Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center","volume":"17","author":"Elsayem","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0012","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/annonc\/mdp048","article-title":"Palliative sedation therapy does not hasten death: results from a prospective multicenter study","volume":"20","author":"Maltoni","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00520-009-0632-4","article-title":"Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study","volume":"18","author":"Porzio","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0014","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00520-011-1217-6","article-title":"Palliative sedation at the end of life at a tertiary cancer center","volume":"20","author":"Caraceni","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpainsymman.2018.03.008","article-title":"Palliative sedation in terminal cancer patients admitted to hospice or home care programs: does the setting matter? Results from a national multicenter observational study","volume":"56","author":"Caraceni","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2512\/jspm.14.169","article-title":"The effect of continuous subcutaneous infusion of chlorpromazine on refractory delirium in advanced cancer: retrospective study","volume":"14","author":"Kiuchi","year":"2019","journal-title":"Palliat Care Res"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-684X-12-2","article-title":"Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review","volume":"12","author":"Dietz","year":"2013","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0018","doi-asserted-by":"crossref","first-page":"564","DOI":"10.12968\/hosp.1999.60.8.1175","article-title":"Levomepromazine (methotrimeprazine) and the last 48 hours","volume":"60","author":"O'Neill","year":"1999","journal-title":"Hosp Med"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0019","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/026921639701100208","article-title":"A comparison of the use of sedatives in a hospital support team and in a hospice","volume":"11","author":"Stone","year":"1997","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archinte.163.3.341","article-title":"Sedative use in the last week of life and the implications for end-of-life decision making","volume":"163","author":"Sykes","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamainternmed.2016.7491","article-title":"Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial","volume":"177","author":"Agar","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0022","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jama.2017.11468","article-title":"Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial","volume":"318","author":"Hui","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0023","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1470-2045(20)30307-7","article-title":"Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial","volume":"21","author":"Hui","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-13-17","article-title":"The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice","volume":"13","author":"Bush","year":"2014","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2512\/jspm.11.331","article-title":"Development and linguistic validation of the Japanese version of the modified Richmond Agitation-Sedation Scale","volume":"11","author":"Imai","year":"2016","journal-title":"Palliat Care Res"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0026","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpainsymman.2023.01.004","article-title":"Visualizing how to use antipsychotics for agitated delirium in the last days of life","volume":"65","author":"Imai","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0027","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archinte.160.6.786","article-title":"Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study","volume":"160","author":"Lawlor","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0028","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/026921601678576185","article-title":"Communication capacity scale and agitation distress scale to measure the severity of delirium in terminally ill cancer patients: a validation study","volume":"15","author":"Morita","year":"2001","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0029","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.genhosppsych.2020.09.001","article-title":"Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: a large-scale multicenter prospective observational study in real-world palliative care settings","volume":"67","author":"Maeda","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.psym.2017.05.005","article-title":"Validation of a nurse-based delirium-screening tool for hospitalized patients","volume":"58","author":"Hargrave","year":"2017","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0031","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/pon.5499","article-title":"Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients?","volume":"29","author":"Uchida","year":"2020","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpainsymman.2024.02.008_bib0032","unstructured":"Japan Clinical Oncology Group. Cancer Therapy Evaluation Program, Common terminology criteria for adverse events v4.0 - JCOG. Available at http:\/\/www.jcog.jp\/doctor\/tool\/ctcaev4.html. Accessed July 27, 2013."}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392424000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392424000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T13:17:38Z","timestamp":1720790258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392424000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0885392424000745"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.02.008","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}